BioCentury
ARTICLE | Company News

FDA panel to consider easing Lotronex REMS

July 8, 2013 11:34 PM UTC

FDA reviewers said the REMS with elements of safe use (ETASU) for irritable bowel syndrome drug Lotronex alosetron from Prometheus Laboratories Inc. is effective but may include a requirement that is ...